Trial Profile
Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Dose Almorexant, an Orexin Receptor Antagonist, in Healthy Elderly Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Sep 2013
Price :
$35
*
At a glance
- Drugs Almorexant (Primary) ; Zolpidem
- Indications Sleep disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 03 Sep 2013 New trial record